GlassScriptPhysician profile
Ahmed Mohamed
NPI 1750420626
$4,330.09
in general payments reported to CMS, 2019-2025
21 companies · $48.43 in 2025
The $48.43 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $210 · 2021: $561 · 2022: $207 · 2023: $1,596 · 2024: $1,707 · 2025: $48.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $351.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $3,000.00 | 2023-2024 | |
| Eisai INC. | $227.42 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $201.86 | 2023-2024 | Rexulti, Nuedexta |
| Abbvie INC. | $165.06 | 2021-2023 | |
| Avanir Pharmaceuticals, INC. | $153.06 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $92.34 | 2021-2025 | Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $80.59 | 2020-2023 | Trintellix |
| Neos Therapeutics, LP | $68.99 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.97 | 2021 | |
| Allergan, INC. | $39.40 | 2020 | |
| Lundbeck LLC | $35.83 | 2020 | |
| Axsome Therapeutics, INC. | $34.41 | 2024 | Auvelity |
| Corium, LLC | $33.28 | 2025 | Azstarys |
| Janssen Pharmaceuticals, INC | $24.06 | 2022 | |
| Aytu Biopharma, INC. | $22.16 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $20.83 | 2023 | Sublocade |
| Jazz Pharmaceuticals INC. | $19.35 | 2020 | |
| Ironshore Pharmaceuticals INC. | $18.85 | 2022 | |
| Almatica Pharma LLC | $18.36 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.83 | 2021 | |
| Alfasigma USA, INC. | $15.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Mohamed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.